Markus Moehler

26.2k citations
322 papers · 8.9k · 3 hit papers · h-index 48

Impact in

    • Gastrointestinal Tumor Research and Treatment
  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research

Papers in

    • Colorectal Cancer Treatments and Studies 88
    • Cancer Immunotherapy and Biomarkers 44
    • Pancreatic and Hepatic Oncology Research 19
    • Gastric Cancer Management and Outcomes 136
    • Lung Cancer Treatments and Mutations 25

Markus Moehler

313 papers receiving 8.7k citations

Markus Moehler's Hit Papers

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 2018 · 386 citations
3860+4+8Years since publication200400600

Peers

Markus Moehler
Comparison fields: 5 of 114
  • Gastroenterology 842
  • Oncology 4.2k
  • Pulmonary and Respiratory Medicine 3.0k
  • Cancer Research 864
  • Surgery 2.1k
Replace Neil H. Segal with:
Neil H. Segal United States
Aatur D. Singhi United States
Nobuhiko Tanigawa Japan
Tetsuro Kubota Japan
Michele Orditura Italy
G.J.A. Offerhaus Netherlands
Srinivasan Madhusudan United Kingdom
Sachiyo Nomura Japan
Satoru Iwasa Japan
Christophe Rosty Australia
Markus Moehler relative to Neil H. Segal United States Neil H. Segal's profile →
Citations per field
00.5×2.7×
Neil H. Segal · 1×
Citations per year

Countries citing papers authored by Markus Moehler

Since Specialization
Citations

This map shows the geographic impact of Markus Moehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Moehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Moehler more than expected).

Fields of papers citing papers by Markus Moehler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Moehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Moehler. The network helps show where Markus Moehler may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Moehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Moehler Line = papers co-authored together Markus Moehler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 322 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chemotherapy for advanced gastric cancer
Hit paper breakdown →
2017742
2
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Hit paper breakdown →
2013640
3
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Hit paper breakdown →
2018386
4 2005228
5 2009180
6 2009178
7 2010158
8 2012147
9 2006146
10 2019143
11 2020141
12 2017116
13 2012108
14 2010106
15 2017100
16 200599
17 201297
18 200497
19 202097
20 202296

About Markus Moehler

Markus Moehler is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Gastroenterology and Molecular Biology, having authored 322 papers that have together received 8.9k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (136 papers), Colorectal Cancer Treatments and Studies (88 papers), Esophageal Cancer Research and Treatment (59 papers), Gastrointestinal Tumor Research and Treatment (45 papers), Cancer Immunotherapy and Biomarkers (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (41 papers), Lung Cancer Treatments and Mutations (25 papers) and Pancreatic and Hepatic Oncology Research (19 papers). The work is most often cited by research in Gastroenterology (842 citations), Oncology (4.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Cancer Research (864 citations) and Surgery (2.1k citations). Markus Moehler has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Peter R. Galle, Dorothea Wagner, Florian Lordick, Ines Gockel, Wilfried Grothe, Wei Peng Yong, Jingshan Ho, Bee‐Choo Tai, Susanne Unverzagt and Nicholas Syn. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, BMC Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact